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A human phospholipid phosphatase activated by a
transmembrane control module
Christian R. Halaszovich,1,* Michael G. Leitner,1,* Angeliki Mavrantoni,* Audrey Le,†
Ludivine Frezza,§ Anja Feuer,* Daniela N. Schreiber,* Carlos A.Villalba-Galea,2,†
and Dominik Oliver2,*
Institute of Physiology and Pathophysiology,* Philipps-Universität Marburg, 35037, Marburg, Germany;
Department of Physiology and Biophysics,† Virginia Commonwealth University, Richmond, VA 23298;
and Department of Biochemistry and Molecular Biology,§ The University of Chicago, Chicago, IL 60637

Supplementary key words phosphoinositides • voltage sensor •
electrochemical coupling •ion channel • lipid signaling

The recent discovery of voltage-sensitive phosphatases
(VSPs) (1) established a novel molecular principle of electrochemical coupling: VSPs directly mediate the degradation of phosphoinositides in response to depolarization of
the membrane potential (2, 3). These so-far-unique electro-enzymes consist of a transmembrane voltage sensor
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domain (VSD) homologous to the voltage sensors of
voltage-gated ion channels and an intracellular C-terminal
catalytic domain (CD) with high similarity to the tumor
suppressor lipid phosphatase, PTEN (Fig.1A) (1). The enzymatic activity of the CD is controlled by the VSD via an
intramolecular conformational switch (4, 5). At typical
negative resting voltages, the CD is inactive and is rapidly
activated at more-positive (depolarized) voltages. The VSP
homologs characterized to date are phosphoinositide
5-phosphatases that degrade the major signaling phospholipids PI(4,5)P2 and PI(3,4,5)P3 (2). Both phosphoinositides have key signaling roles in many cellular processes,
including cell proliferation and differentiation, cytoskeletal dynamics, membrane trafficking, and control of ion
channels (6, 7). Although little is known to date about the
biological functions of VSPs, the ubiquitous roles of phosphoinositides and of electrical signaling suggest a potential impact on a large spectrum of cellular processes.
The principle of operation of VSPs was initially demonstrated for Ci-VSP, the prototypic VSP from the invertebrate chordate Ciona intestinalis. Subsequently, functional
vertebrate VSPs have been identified in fishes and amphibia (8, 9). The VSP gene is also conserved in mammals
(10). In general, there appears to be one VSP homolog in
mammalian genomes; in the human genome, however,
there are two expressed homologs, TPTE and TPTE2 (also
termed TPIP) and additional pseudo-genes (10, 11). TPTE
conforms to the architecture of VSPs, but it lacks phosphatase activity due to amino acid exchanges in the catalytic CX5R motif in the P-loop of the phosphatase domain
(12). In contrast, the intracellular domain of TPTE2/TPIP
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Abstract In voltage-sensitive phosphatases (VSPs), a transmembrane voltage sensor domain (VSD) controls an intracellular phosphoinositide phosphatase domain, thereby
enabling immediate initiation of intracellular signals by
membrane depolarization. The existence of such a mechanism in mammals has remained elusive, despite the presence of VSP-homologous proteins in mammalian cells, in
particular in sperm precursor cells. Here we demonstrate
activation of a human VSP (hVSP1/TPIP) by an intramolecular switch. By engineering a chimeric hVSP1 with enhanced plasma membrane targeting containing the VSD of a
prototypic invertebrate VSP, we show that hVSP1 is a phosphoinositide-5-phosphatase whose predominant substrate is
PI(4,5)P2. In the chimera, enzymatic activity is controlled by
membrane potential via hVSP1’s endogenous phosphoinositide binding motif. These findings suggest that the
endogenous VSD of hVSP1 is a control module that initiates
signaling through the phosphatase domain and indicate a
role for VSP-mediated phosphoinositide signaling in
mammals.—Halaszovich, C. R., M. G. Leitner, A. Mavrantoni,
A. Le., L. Frezza, A. Feuer, D. N. Schreiber, C. A. Villalba-Galea,
and D. Oliver. A human phospholipid phosphatase activated
by a transmembrane control module. J. Lipid Res. 2012. 53:
2266–2274.
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localized predominantly to intracellular compartments when
transfected into culture cells, we generated a chimeric
hVSP1 containing the N-terminus from Ci-VSP that robustly
targets to the plasma membrane. Functional assays showed
that hVSP1 is a phosphoinositide 5-phosphatase that can
be activated via the N-terminal VSD. These findings support
a role for VSP-mediated phosphoinositide signaling in mammalian spermatocyte differentiation or sperm function.

MATERIALS AND METHODS
Cloning of the hVSP1CiV chimera and full-length hVSP1

has phosphoinositide phosphatase activity in vitro (11).
According to its conserved catalytic center, it is apparently
the bona-fide ortholog of nonmammalian VSPs and the
VSP homologs in other mammals [e.g., mouse PTEN2
(13), also termed mTpte (14)]. For consistent nomenclature, we will thus rename both homologs hVSP1 (for
TPIP/TPTE2) and hVSP2 (for human TPTE).
Various splice variants of hVSP1 have been reported that
mainly differ in the VSD-homologous transmembrane domain. Because all splice variants examined so far in expression systems lacked localization to the plasma membrane, it
is unknown whether enzymatic activity is controlled by the
VSD-homologous domain and, specifically, whether it is
sensitive to membrane potential. Consequently the prevalence of VSP-mediated signaling in mammals has remained
unknown. In human and mouse, VSPs are expressed mainly
in the testis (10, 13) but also in brain and stomach (11).
Cellular expression has been detected in secondary spermatocytes and early spermatids in human and mouse (10, 13),
whereas in the tunicate, Ciona intestinalis, Ci-VSP, is also
found in mature sperm (1). Thus, a role of VSPs in phosphoinositide signaling in mammalian spermatogenesis or
sperm physiology is an exciting possibility.
Here, we address the enzymatic properties and the molecular mechanism of activation of hVSP1 using fluorescent
sensors for phosphoinositides in living cells. Because hVSP1

Plasmids and transfection of mammalian cells
The following plasmids were used: Ci-VSP (UniProt acc. #
Q4W8A1) or hVSP variants in pRFP-C or pRFP-N vector;
PLC␦1-PH (P51178), Btk-PH (Q06187), OSBP-PH (P22059) in
pEGFP-N1 vector; TAPP1-PH (Q9HB21) in FUGW vector (contains eGFP); Bovine phosphatidylinositol 3-kinase p110␣ (constitutively active mutant K227E; P32871); Lyn11-GFP (P07948) in
pcDNA3; and KCNQ4 (Kv7.4, P56696-1) in pBK-CMV.
CHO cells plated on glass coverslips or glass-bottom dishes were
transfected with these plasmids using JetPEI transfection reagent
as described (2, 15). VSPs were transfected individually or cotransfected with either Lyn11-GFP, phosphoinositide sensors, or KCNQ4
potassium channel. For experiments on 3-phosphorylated phosphoinositides, a constitutively active PI-3-kinase [p110␣(K227E)]

Human voltage-sensitive PIP2 phosphatase
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Fig. 1. Generation of a functional hVSP1 chimera targeted to the
plasma membrane. A: Domain structure of Ci-VSP and human
VSP1 (full-length variant) and construction of the chimera hVSP1CiV.
Inset shows catalytic CX5R motif. S1-S4, transmembrane segments
1–4; PBM, phosphoinositide binding motif; CD, catalytic domain;
PD, phosphatase domain; C2, C2 domain. B: Subcellular localization of N-terminally mRFP-fused VSP constructs transfected into
CHO together with the plasma membrane marker Lyn11-GFP (37)
(scale bar, 10 µm). C: Sensing currents recorded from CHO cells in
response to a voltage pulse (timing as indicated in gray) from the
holding potential (⫺60 mV for Ci-VSP and hVSP1 or ⫺100 mV for
hVSP1CiV) to +80 mV.

mRFP-tagged hVSP1CiV was constructed by amplifying the coding sequence for mRFP and amino acids 1 to 239 of Ci-VSP from a
pRFP-C1-Ci-VSP plasmid (2). A HindIII restriction site was added
using reverse primer 5′-ATA TAA GCT TGT TGA TGG GAA TAA
AAT ATT C-3′. The resulting amplicon was digested for 30 min
at 37°C with fast-digest HindIII, BamHI, and DpnI (Fermentas,
St. Leon-Rot, Germany) to avoid carryover of template DNA.
Amino acids 120 to STOP of hVSP1-3 [TPIP␣ (11)] were amplified
using forward primer 5′-GAC AAG CTT GAA AAG CTG ATG AGA
AGG-3′ to insert a guanine to form a HindIII restriction site. The
resulting fragment was digested with HindIII and BamHI and ligated to the corresponding mRFP-Ci-VSP fragment. The additional guanine was deleted from the fusion construct by mutagenesis
PCR using PfuUltra DNA Polymerase AD (Stratagene, Waldbronn,
Germany). The complete coding sequence of the resulting construct was verified by sequencing.
Full-length hVSP1 (previously termed TPTE2-1 or TPIP␥, UniProt accession # Q6XPS3) was cloned from a commercial RNA
preparation from human testis (Invitrogen; Darmstadt, Germany).
Briefly, hVSP1 cDNA was obtained by RT-PCR using semi-nested
PCR as described elsewhere (10). PCR products were subcloned
in pJET2.1/blunt vector (Fermentas) and sequenced. Two novel
hVSP1 splice variants were identified, lacking either aa 40 to 59
or aa 434 to 464 (numbering according to the full-length sequence). The latter variant was subcloned into pRFP-C, yielding
an mRFP-hVSP1 fusion construct. Finally, the C terminus was
replaced with the full-length C terminus of hVSP1 isoform 3,
yielding the full-length hVSP1 clone. The hVSP1-mRFP fusion
construct was obtained by subcloning full-length hVSP1 into
pRFP-N vector. The hVSP1hV2-3N chimera was constructed from
amino acids 1–50 from hVSP2-3 (TPTE␥, acc. # P56180-3) in
pRFP-C vector and amino acids 71–522 from hVSP1. A KpnI restriction site was added at the site of fusion of both constructs
using forward mutagenesis primer 5′-GCA TTC AAT GGT ACC
ATC CTT TGC ATT TGG-3′. The KpnI restriction site was removed from the fusion construct by mutagenesis PCR.
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was additionally cotransfected (2). Experiments were done 24–48 h
posttransfection, with cells selected for robust expression of the
VSP constructs on the basis of mRFP fluorescence.

Whole-cell patch clamp
CHO cells were whole-cell voltage clamped with an EPC-10
(HEKA; Lambrecht, Germany) or Axopatch 200B amplifier (Molecular Devices; Sunnyvale, CA). Sensing currents were isolated
using a P/-10 protocol. Intracellular solution contained (in mM):
KCl, 135; MgCl2, 2.5; CaCl2, 2.41; EGTA, 5; HEPES, 5; and
Na2ATP, 3, pH 7.3 (with KOH). Extracellular solution, also used
for imaging experiments (mM): NaCl, 144; KCl, 5.8; NaH2PO4,
0.7; glucose, 5.6; CaCl2, 1.3; MgCl2, 0.9; and HEPES, 10; pH 7.4
(with NaOH). Patch pipettes were pulled from borosilicate glass
(Science Products; Hofheim, Germany). KCNQ4 (Kv7.4) current
recordings were sampled at 5 kHz and low-pass-filtered at 2 kHz.
Series resistance in these experiments typically was below 5 M⍀
and was compensated by 80–90%.

Fluorescence microscopy

Oocyte electrophysiology
For expression in Xenopus oocytes, hVSPCiV was cloned into the
pBSTA vector. Point mutations were made by PCR using mismatched primers containing the mutation. For RNA synthesis,
DNA was linearized with NotI and transcribed using T7 RNA polymerase. KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) constructs for expression in Xenopus oocytes (vector pTLN; kindly provided by
T. Jentsch) were linearized with MluI and HpaI, respectively, and
RNA was transcribed using SP6 RNA polymerase (Ambion, Frankfurt, Germany). For coexpression of KCNQ channels with potassium currents, Xenopus oocytes were injected with 10 ng of RNA of
each construct and incubated for 2–3 days at 12–18°C in a solution
containing 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2,
and 10 mM HEPES, pH 7.5. For sensing currents, Xenopus oocytes
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RESULTS
hVSP1 may be subject to extensive splicing yielding
differentially truncated VSD domains (10). The described
N-terminal truncations appeared incompatible with the
function of the domain as a voltage sensor. Moreover,
truncated splice variants were not targeted to the plasma
membrane (see supplementary Fig. I) (11). We therefore
cloned the full-length variant (hVSP1-1) that corresponds
to the canonical isoform according to UniProt (accession
# Q6XPS3) (17). When transfected into CHO cells (Fig. 1B)
or HEK293 cells (see supplementary Fig. IB), localization
of even this full-length protein was restricted to intracellular compartments, possibly the Golgi apparatus, as suggested previously for mouse VSP1 (mPTEN2) (13). This
subcellular localization was not the result of N-terminal
mRFP fusion, because hVSP1-1 with a C-terminal mRFP
showed the same localization (see supplementary Fig. IB).
Accordingly, electrophysiological examination did not reveal sensing currents, the electrical signature of a functional VSD as found in Ci-VSP (Fig. 1C) (1). Moreover,
the intracellular localization of hVSP1 in the expression
system prohibited a direct assessment of voltage-dependent
activity of this putative lipid phosphatase. Interestingly, a
short splice variant of the paralog, hVSP2-3 (TPTE␥), targets robustly to the plasma membrane (11), although functional examination showed absence of sensing currents,
indicating a nonfunctional VSD in hVSP2 (see supplementary Fig. IC). Given the distinct subcellular localization of
both hVSPs, we considered a possible role of their distinct
cytoplasmic N-termini in membrane targeting. However,
replacement of the hVSP1 N-terminus with the corresponding terminus of hVSP2-3 also failed to localize the protein
to the plasma membrane (see supplementary Fig. IA, B).
We therefore adopted an approach that we developed previously to examine the function of phosphoinositide phosphatases (15). Thus, we generated a chimeric hVSP1 variant
by replacing its entire VSD with the highly homologous

Downloaded from www.jlr.org by guest, on May 9, 2017

Subcellular localization was imaged in living cells with a Zeiss
LSM710 confocal microscope (Carl Zeiss AG; Jena, Germany)
equipped with a W-Plan Apochromat 20×/1.0 DIC M27 objective. Laser lines used were 561 nm for mRFP and 488 nm for
GFP, and detection wavelength ranges were 582–754 nm and
493–582 nm, respectively.
TIRF imaging was done as described previously (2). Briefly, a
BX51WI upright microscope equipped with a TIRF-condenser
(Olympus) and a 488 nm laser was used. Images were acquired
with a CCD camera using TILLvision software (TILL-photonics;
Gräfelfing, Germany). Where applicable, the electrophysiology
setup was synchronized to the imaging setup. The frame interval
was 3 s. TIRF imaging data were analyzed using TILLvision and
IgorPro (Wavemetrics; Lake Oswego, OR). Regions of interest
(ROIs) encompassed the footprint of a single cell, excluding cell
margins to avoid movement artifacts. Normalized fluorescence
intensity (F/F0) was calculated pixelwise from the TIRF signal
intensity F and the initial fluorescence intensity F0, which was calculated as the average over the baseline interval. Background
correction was applied in this process. The F/F0 trace was then
calculated by framewise averaging over the ROI. F/F0 traces were
corrected for bleaching according to monoexponential fits to
the baseline interval as described before (15).
Steady-state fluorescence voltage relations were derived as reported previously (2). Data obtained from individual cells were
fitted with a Boltzmann function F = Fmin + (Fmax-Fmin)/[1 +
exp((V-V1/2)/s))], where F is the recorded TIRF intensity, V is the
holding potential, V1/2 is the voltage at the half-maximal response,
and s describes the steepness of the curve. Data were normalized
to Fmax-Fmin as derived from the fit for each individual cell.

were injected with 20–50 ng of RNA, and electrophysiological measurements were performed after 3 days of incubation at 15°C.
Potassium currents mediated by KCNQ channels were recorded by two-electrode voltage clamp. The extracellular recording solution contained 4–8 mM KOH, 112–116 mM NMG, 120 mM
MeSO3 (methanesulfonate), 10 mM HEPES, and 2 mM CaCl2,
pH 7.4. Sensing currents were measured 3–4 days after injection
with the cut-open oocyte voltage clamp technique as described
previously (16). The external recording solutions contained
120 mM NMG-MeSO3 (methanesulfonate), 10 mM HEPES, and
2 mM CaCl2, pH 7.4, whereas internal solutions contained 120 mM
NMG-MeSO3, 10 mM HEPES, and 2 mM EGTA, pH 7.4. Currents
were measured in response to voltage steps (10 s interval) from a
holding potential of ⫺60 mV, without leak subtraction during
acquisition. Capacitance transient currents were compensated
using the amplifier’s compensation circuit. Recordings were performed using a homemade acquisition software based on the
graphical programming environment LabVIEW (National Instruments; Austin, TX). The software controlled an NI USB-6251
BNC interface (National Instruments).
All experiments were performed at room temperature. Data
are given as mean ± standard error of the mean (± SE).
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domain of the prototypic Ci-VSP (Fig. 1A, lower panel).
We will refer to this chimera as hVSP1CiV. hVSP1CiV was
robustly targeted to the plasma membrane (Fig. 1B). Depolarizing voltage steps revealed sensing currents similar to Ci-VSP, indicating intact functionality of the VSD
in the chimeric hVSP1 (Fig. 1C). Expression of hVSP1CiV
in Xenopus oocytes confirmed functionality and allowed
for a detailed examination of sensing currents, revealing
the sigmoidal dependence on membrane voltage that
characterizes voltage sensor domains (see supplementary Fig. II).

Enzymatic activity and specificity of hVSP1
We tested for lipid phosphatase activity of hVSP1CiV
in vivo, using GFP-fused phosphoinositide binding protein domains as fluorescent phosphoinositide sensors
(18). Association of these probes to the membrane reports on the concentration of specific phosphoinositide
species, and was measured quantitatively by TIRF microscopy (2, 15).
In cells coexpressing hVSP1CiV and the PI(4,5)P2 sensor
PHPLC␦1-GFP, depolarization of the membrane potential
via whole-cell patch clamping resulted in the reversible

Downloaded from www.jlr.org by guest, on May 9, 2017

Fig. 2. Phosphatase activity and substrate specificity of hVSPCiV. A: TIRF images of a CHO cell coexpressing
mRFP-hVSP1CiV and PHPLC␦1-GFP acquired before (left), during (middle) and after (right) depolarization by
whole-cell voltage clamp (scale bar, 10 µm). B, C: TIRF signals in response to step depolarization (⫺100 to
+80 mV, gray shading) from cells expressing RFP-hVSP1CiV with the PI(4,5)P2 sensor PHPLC␦1-GFP (B) or the
PI(4)P sensor PHOSBP-GFP (C). Decrease and increase of fluorescence signals indicate dissociation and association of the probes from and to the membrane, respectively. Voltage-dependent sensor translocation was
not observed with the hVSP1CiV(C363S) mutant. D: Representative currents mediated by KCNQ4 channels
with or without coexpression of the VSPs indicated. Holding potential was ⫺60 mV (controls and coexpression of Ci-VSP) or ⫺100 mV (hVSP1CiV). E: Mean KCNQ4 current amplitudes from experiments as in D. F, G:
Depolarization-induced changes of TIRF intensities in cells cotransfected with hVSP1CiV(D136N) and the
PI(3,4,5)P3 probe PHBtk (F) or the PI(3,4)P2 sensor PHTAPP1 (G) (⫺60 to +80 mV depolarization, gray shading). D136N mutant that activates at more-positive voltages (see Fig. 3) was used to avoid constitutive depletion of slowly synthesized 3-phosphorylated substrates prior to the experiments. Similar results were obtained
with the wild-type VSD (see supplementary Fig. IV). Error bars indicate standard error of the mean.

Human voltage-sensitive PIP2 phosphatase

2269

Supplemental Material can be found at:
http://www.jlr.org/content/suppl/2012/08/15/jlr.M026021.DC1
.html

2270

Journal of Lipid Research Volume 53, 2012

words, hVSP1 has the same enzymatic properties as previously determined for the prototypic nonmammalian VSP,
Ci-VSP.
Control of activity by the VSD
Next, we addressed the regulation of enzymatic activity
in hVSP1. Is hVSP1 a functional mammalian VSP? Because its subcellular localization precluded the direct
analysis of the native protein in the expression system, we
analyzed hVSP1CiV to derive information on the regulation of hVSP1.
First, we note that the enzymatic activity is switched on
rapidly (i.e., in less than a second) upon depolarization of
the membrane potential. Similarly, hVSP1CiV rapidly returns to an inactive state upon repolarization, as reported
by recovery of the PI(4,5)P2 level (Fig. 2B). This recovery
results from cellular resynthesis of PI(4,5)P2 by endogenous PI-5-kinase activity (2, 21). Second, a detailed analysis
using PHPLC␦1-GFP to monitor PI(4,5)P2 concentrations
showed that phosphatase activity increased with the degree of depolarization in a sigmoidal, saturating manner
Downloaded from www.jlr.org by guest, on May 9, 2017

dissociation of the probe from the membrane (Fig. 2A, B)
indicating depletion of PI(4,5)P2. This depletion resulted
from phosphatase activity of hVSP1, because effects on
PHPLC␦1 localization and PI(4,5)P2 concentration were
abolished when an inactivating mutation (C363S) was introduced into the catalytic CX5R motif (Fig. 2B; cf. Refs.
15, 19). Thus, hVSP1 has phosphoinositide phosphatase
activity in vivo, and, specifically, dephosphorylates PI(4,5)P2.
Moreover, the depletion of PI(4,5)P2 in response to depolarization shows that in hVSP1CiV, enzymatic activity is regulated by membrane voltage via the attached VSD.
Initial in vitro work on the isolated CD suggested that
hVSP1 has 3-phosphatase activity (11), which would be incompatible with the observed consumption of cellular
PI(4,5)P2 but should instead produce PI(4,5)P2 from
PI(3,4,5)P3 (15). We therefore performed a detailed analysis of the enzymatic specificity of hVSP1, using fluorescent probes with distinct phosphoinositide specificities.
Activation of hVSP1CiV by depolarization resulted in an
increase of the PI(4)P concentration, as shown by translocation of PHOSBP-GFP from the cytosol to the plasma membrane (Fig. 2C). Quantitative considerations indicate that
the additional PI(4)P results from dephosphorylation of
PI(4,5)P2. Thus, PI(4,5)P2 and PI(4)P together make up
the bulk of phosphoinositides in the plasma membrane,
whereas all other phosphoinositides have much lower
steady-state concentrations in this compartment (6, 20, 21).
Therefore, PI(4,5)P2 is the only available source for a
substantial increase of PI(4)P by phosphatase activity. In
conjunction with the observed depletion of PI(4,5)P2, this
finding directly indicates that hVSP1 is a 5-phosphatase
that converts PI(4,5)P2 to PI(4)P. To independently confirm the results obtained with fluorescent sensors, we
tested the effect of hVSP1CiV on another type of PI(4,5)P2
biosensor, the KCNQ (Kv7) potassium channels. These
channels specifically require PI(4,5)P2, but not PI(4)P,
for their activity (22). In cells coexpressing KCNQ4 with
hVSP1CiV, activation of the channels upon depolarization
was strongly reduced and the currents showed time-dependent deactivation (Fig. 2D, E). Such channel deactivation was not observed in cells expressing KCNQ4 only or
the catalytically inactivated mutant hVSP1CiV(C363S). Similar results were obtained with Xenopus oocytes expressing
heteromeric KCNQ2/3 channels together with hVSP1CiV
(see supplementary Fig. III). These findings are consistent
with depletion of PI(4,5)P2 by hVSP1.
Measurements using fluorescent probes for 3-phosphorylated phosphoinositides further revealed that hVSP1 can
also use PI(3,4,5)P3 as an alternative substrate, again cleaving the phosphate at position 5. Thus, activation of hVSP1CiV
reduced the concentration of PI(3,4,5)P3, as measured
with the PI(3,4,5)P3 probe, PHBtk-GFP (Fig. 2F), and at the
same time increased the membrane’s PI(3,4)P2 concentration as reported by increased membrane binding of the
specific PI(3,4)P2 probe PHTAPP1-GFP (Fig. 2G).
Together, the changes in the various PI isoforms and
the inhibition of PI(4,5)P2-sensitive KCNQ channels demonstrate that in vivo hVSP1 is a 5-phosphatase that can dephosphorylate both PI(4,5)P2 and PI(3,4,5)P3. In other

Fig. 3. Activity of the intracellular CD is controlled by the VSD.
A: Representative depolarization-induced TIRF fluorescence responses from cells expressing PHPLC␦1-GFP together with mRFPhVSPCiV or its D136N mutant. Membrane potential was subjected
to a family of depolarizing voltage pulses of increasing amplitude
(20 mV increment). Black traces were obtained at depolarization
to ⫺20 mV. B: Depolarization-induced TIRF fluorescence changes
obtained as in A from cells expressing Ci-VSP or Ci-VSP(D136N).
Black traces were obtained at depolarization to ⫺20 mV. C: Normalized steady-state fluorescence-voltage relationship from recordings as in A and B. Voltage at half-maximal fluorescence decrease
(V1/2) was calculated by fitting a Boltzmann function (continuous
line) to the mean data. V1/2 (obtained from fits to data of individual experiments) was ⫺60.2 ± 5.3 mV for hVSP1CiV, ⫺9.4 ± 3.0 for
hVSP1CiV(D136N), 21.3 ± 5.3 mV for Ci-VSP, and 71.6 ± 5.1 mV for
Ci-VSP(D136N).
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(Fig. 3). This tight dependence of activity on voltage indicates close coupling of enzymatic activity to the dynamics
of the VSD characterized by the sensing currents (see supplementary Fig. II). Direct functional coupling between
both domains also predicts that altering the voltage dependence of the VSD affects the activation of the CD by
membrane potential (3). In the prototypic Ci-VSP, the
mutation D136N in the S2 helix of the VSD shifted its voltage dependence to more-depolarized voltages by about
+50 mV. Accordingly, activation of the CD required stronger depolarization (Fig. 3B, C). Activation of hVSP1CiV
occurred at substantially more hyperpolarized potentials
than activation of Ci-VSP (cf Ref. 2). However, in hVSP1CiV,
the D136N mutation also shifted voltage dependence of
phosphatase activity by +50 mV (Fig. 3A, C), supporting
the same close coupling between VSD and CD in hVSP1CiV
as found in Ci-VSP.
Electrochemical coupling in Ci-VSP is mediated by a
phosphoinositide binding motif (PBM), also referred to
as the linker (5, 23, 24), connecting the VSD and the
CD (Fig. 4A). It has been suggested that the VSD controls
the activity of the CD by modulating the binding of the

DISCUSSION

Fig. 4. Functional coupling of the enzymatic domain to the VSD
is mediated by the PBM. A: Critical basic residues (red) are conserved between the PBMs of Ci-VSP and hVSP1. Asterisks indicate
positions mutated to glutamine or alanine. B: Charge-neutralizing
mutations K252Q and R253Q in the PBM of hVSP1 greatly reduce
voltage-dependent activation of hVSP1CiV. Experiments were performed as in (Fig 1A, B), and data from cells expressing wt hVSP1CiV
are replotted from Fig. 1B for comparison. Depolarization to 80 mV
is indicated by shaded area [N = 8 (K252Q) or 9 (R253Q) cells]. C:
Average depolarization-activated enzymatic activity for the PBM
mutants indicated. Activity is quantified as the degree of dissociation of PHPLC␦1-GFP from the membrane, measured as in B.

Enzymatic properties of mammalian VSPs
Here, we show and characterize for the first time activity
of a mammalian VSP in living cells and demonstrate that
this activity is controlled by a VSD-homologous domain.
Specifically, we demonstrate that hVSP1 is a phosphoinositide 5-phosphatase that degrades the major signaling
phosphoinositides PI(4,5)P2 and PI(3,4,5)P3.
This finding may be unexpected, given that previous
in vitro experiments with the isolated intracellular CD of
human or mouse VSP1 suggested 3-phosphatase properties
(11, 13). However, our conclusion is based on several lines
of evidence obtained in living cells. Notably, the same responses of phosphoinositide biosensors are found with the
phosphoinositide 5-phosphatase Ci-VSP (2, 3). For comparison, rapid activation of the bona-fide 3-phosphatase, PTEN,
results in a completely different pattern of phosphoinositide concentration changes when examined using the same
approach. Thus, biosensor responses to PTEN activation
showed synchronous decrease of PI(3,4,5)P3 and PI(3,4)P2,
increase of PI(4,5)P2, but no change in PI(4)P (15).
Moreover, in line with our conclusion, previous
functional assays in living cells did not support a role in
3-phosphoinositide signaling (11), and recent in vitro data
are fully consistent with the 5-phosphatase activity (25).
The apparently different enzymatic specificity previously
observed in vitro might therefore point to the importance
of the native membrane environment in determining the
stereochemistry of interaction of the phosphatase with its
phospholipid substrate.
Unexpectedly, a recent report suggested an additional
3-phosphatase activity of Ci-VSP, because in Xenopus oocytes,
Human voltage-sensitive PIP2 phosphatase
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PBM to the membrane (5, 15) or its interaction with a
“gating loop” that controls substrate access to the active
site of the CD (23, 24). Thus, mutation of conserved cationic residues in the PBM uncouples enzymatic activity
from membrane potential in Ci-VSP (4, 5). The basic PBM
residues previously identified as critical for electrochemical coupling in Ci-VSP are fully conserved in hVSP1 (Fig. 4A),
indicating that the same mechanism may mediate activation of the CD hVSP1.
To test this hypothesis, we mutated K252 or R253 to glutamine. These mutations have previously been shown to
drastically reduce voltage-dependent activity of Ci-VSP
by uncoupling the VSD and the PD, while leaving the
enzymatic activity of the isolated CD largely intact (4).
In hVSP1CiV, these mutants showed strongly reduced
depolarization-dependent activity (Fig. 4B, C). Additionally, further combinatorial alanine replacement of cationic residues within the PBM that are essential for activity
of Ci-VSP (5) fully abrogated phosphatase activity of
hVSP1CiV upon depolarization, as shown in Fig. 4C.
These findings indicate that the activation of the enzymatic domain of hVSP1 involves the endogenous PBM,
and proceeds via a mechanism similar to electrochemical
coupling in the prototypic Ci-VSP.

Supplemental Material can be found at:
http://www.jlr.org/content/suppl/2012/08/15/jlr.M026021.DC1
.html

Functional role of hVSP1
Our results on the enzymatic properties of hVSP1 indicate that mammalian VSPs are involved in PI(4,5)P2 or
PI-3 signaling pathways or contribute to the homeostasis of
these phosphoinositides. The range of possible biological
functions of hVSP1 is constrained by its cellular expression
pattern and subcellular localization. Little is known about
the expression pattern of mammalian VSPs, but available
data on mRNA abundance suggest that it is confined to
specific organs (testis, stomach, brain) (11, 13, 14). Consequently, VSPs may serve cell type-specific functions rather
than mediating general cellular mechanisms. However,
expression may be more widespread during development
(28), as observed for the nonvertebrate Ci-VSP (29) and
the homolog in birds (30).
Notably, the intracellular Golgi-like localization of
hVSPs is in contrast to the plasma membrane localization
of all previously examined nonmammalian VSPs (1, 9, 26).
However, the localization in native cells has not been determined. Meanwhile, it remains possible that the localization observed is an artifact of overexpression in culture
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cells. VSPs localized to the plasma membranes can impact
on the many signaling roles of PI(4,5)P2 and PI(3,4,5)P3/
PI(3,4)P2. In contrast, a role of this 5-phosphatase at the
Golgi membranes is less obvious, inasmuch as the main
phosphoinositide in this compartment is PI(4)P, whereas
there is little PI(4,5)P2 or PI(3,4,5)P3 (31, 32). Accordingly, PI(4)P is a key player, essential for Golgi function,
whereas PI(4,5)P2 seems less important (31). This consideration may also argue in favor of plasma membrane localization of endogenously expressed hVSP1 in native cells. On the
other hand, Golgi-localized VSP may function to ensure low
PI(4,5)P2 levels, as has been suggested for the 5-phosphatase
OCRL that is also associated with the Golgi (33).
The issue of subcellular distribution of hVSP1 also raises
an important question as to the stimulus that activates native hVSP1. Although our current observations were obtained using the voltage sensor chimera hVSP1CiV, the
findings strongly suggest that in native hVSP1, the enzymatic activity is regulated by an intramolecular interaction
of the CD with the endogenous VSD-homologous transmembrane module. Thus, activity was readily controlled
by the exogenous VSD, and the coupling is mediated
through the endogenous PBM of hVSP1, indicating that
all molecular requirements for intramolecular switching
by the VSD are present in mammalian VSPs. Thus, we conclude that the native VSD domain of hVSP1 is a sensor
domain that controls the signaling activity of the VSP. Its
homology to VSDs from bona fide voltage-sensitive VSPs
suggests that it may act as a voltage sensor, which, however,
remains to be examined experimentally.
Recently, Sutton et al. (34) addressed the function of
the VSDs of hVSP1 and hVSP2 using chimeric constructs
in which the S3-S4 segments of the VSDs of both hVSPs
were transplanted into the VSD of Dr-VSP. In these constructs, sensing currents suggested functionality of the chimeric VSD. In contrast, we found that the endogenous
VSD of hVSP2-3 [human TPTE␥ (10)] did not produce
sensing currents, despite robust targeting of this isoform
to the plasma membrane (see supplementary Fig. IC). This
finding may indicate that in hVSP2, the full-length VSD
does not act as a voltage sensor in the physiological range
of membrane potentials. The fact that the VSD is largely
conserved between the hVSP1 and hVSP2 full-length splice
forms (93% sequence identity) might also point toward a
lack of voltage sensitivity in hVSP1. In support of this idea,
the alignment of VSP primary sequences reveals two relevant differences in the VSDs of Ci-VSP versus hVSP. First,
the homolog residue to R232 within the putative S4 helix
of Ci-VSP is a histidine in the hVSPs. This residue has been
proposed as critical for electrochemical coupling (1). Second, the hVSPs feature additional positively charged residues (R171 and R177) close to the extracellular end of the
S4 segment. It was previously observed that in Ci-VSP, neutralization of a positive charge (R217) located in the homologous sequence stretch causes a strong shift in voltage
dependence toward negative potentials (35). Vice versa,
the additional positive charges present in the hVSPs may
position the voltage dependence at very positive potentials
beyond the range that we can assay.
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overexpressed Ci-VSP induced a dissociation of the PI(3,4)P2
probe TAPP1-PH from the membrane at strongly depolarized potentials (25). We have not observed such apparent depletion of PI(3,4)P2 by Ci-VSP in mammalian cells
previously (2). Additional experiments with strong (+80 mV)
and prolonged (>5 min) depolarization also failed to indicate any PI(3,4)P2 hydrolysis either by Ci-VSP or by hVSPCiV
(data not shown). Therefore, it remains to be seen whether
the apparent 3-phosphatase activity is specific for the oocyte expression system.
Alternatively, it might be argued that the exogenous
VSD in hVSPCiV caused changes in the active site, resulting
in altered catalytic selectivity. However, for Ci-VSP it has
been shown that deletion of the VSD does not change the
5-phosphatase nature of its CD (26). Likewise, we have
shown previously that attaching the VSD of Ci-VSP to
PTEN does not affect the catalytic properties of this phosphatase (15). We thus conclude that it is unlikely that attaching the VSD of Ci-VSP to the CD of hVSP1 causes a
switch from a 3- to a 5-phosphatase.
Given the striking structural similarity of the intracellular CD of VSPs to PTEN (15, 27), the distinct enzymatic activities may appear surprising. However, the
catalytic CX5R motif of hVSP (CKGGKGR) differs in a
single position from PTEN (CKAGKGR). In Ci-VSP, this
amino acid contributes strongly to the 5-phosphatase
specificity (26, 27). Additional sites, including glutamate 411 in the catalytic gating loop of Ci-VSP, are also
important for determining substrate selectivity (23, 25).
Further differences in the catalytic center may also contribute to the distinct enzymatic specificities; this remains
to be addressed. Despite this complexity, all CX5R-type
5-phosphatases examined to date display the critical
G variant motif (2, 8, 9, 26), suggesting that not only
hVSP1, but also yet-uncharacterized VSP homologs from
other mammalian species, are 5-phosphatases, because
all share the G variant.

Supplemental Material can be found at:
http://www.jlr.org/content/suppl/2012/08/15/jlr.M026021.DC1
.html
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Therefore, it may be considered that alternative cellular
signals such as pH or lipid composition could operate the
mammalian VSPs. In fact, such hypothetical activation
stimuli may be consistent with Golgi localization observed
in transfected cells, because changes in membrane potential may not be prevalent in this organelle.
Beyond their as yet enigmatic physiological role, nonmammalian VSPs have received attention as powerful experimental tools for the analysis of PI(4,5)P2-dependent
cellular processes (e.g., 20, 36). So far, patch-clamp or
similar electrophysiological techniques have been used to
rapidly switch VSPs and thereby deplete and replenish
PI(4,5)P2 levels. However, to access a broader range of cell
biological processes, it may be advantageous to operate
VSPs without the need for specialized equipment, e.g., by
depolarization via elevation of extracellular K+ (15). The
left-shifted activation range of hVSPCiV in comparison to
Ci-VSP may render this chimera particularly suitable for
this approach, inasmuch as its activation range fits well
with the range of membrane potentials that can easily be
achieved by altering the extracellular K+ concentration.
In summary, our current results suggest that mammalian
VSPs are functional phosphoinositide phosphatases that
mediate membrane-delimited signaling by 5-phosphoinositides at intracellular or plasma membranes and that
may be involved in controlling the phosphoinositide composition of intracellular compartments. To date, expression
of hVSP1 has been observed in testis, brain, and stomach
(11). In particular, the striking finding of hVSP1 expression
in secondary spermatocytes and in spermatids (10, 13) suggests specific roles for VSP-mediated 5-phosphoinositide
signaling in mammalian reproductive physiology.
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